Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sullivan

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Malaria Journal|May 11, 2016
Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regionsAndrew A Adjei, Peter Winch, Amos Laar, et al.
The Journal of Clinical Investigation|April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Nature|May 21, 2010
Chemical genetics of Plasmodium falciparumW Armand Guiguemde, Anang A Shelat, David Bouck, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Malaria Journal|May 11, 2016
Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regionsAndrew A Adjei, Peter Winch, Amos Laar, et al.
The Journal of Clinical Investigation|April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Nature|May 21, 2010
Chemical genetics of Plasmodium falciparumW Armand Guiguemde, Anang A Shelat, David Bouck, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2023
Early Treatment, Inflammation and Post-COVID ConditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|December 14, 2023
Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions"Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio|September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditionsKelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Microbiology Spectrum|November 27, 2023
COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trialFeben Habtehyimer, Xianming Zhu, Andrew D Redd, et al.
The Lancet. Microbe|September 2, 2023
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort studyXianming Zhu, Kelly A Gebo, Alison G Abraham, et al.
Pageof 17